Home / About Us / News

Geistlich Pharma acquires the medical technology company Meta Technologies S.r.l.

Geistlich Pharma has been working successfully with Meta, the medical technology division of C.G.M. S.p.A., for many years. With the acquisition of Meta Technologies S.r.l., Geistlich Pharma is expanding its existing offering as a regeneration specialist by adding a further recognized brand. Meta Technologies S.r.l. will continue its business relationships independently
November 17, 2021

With the acquisition of Meta Technologies S.r.l., Geistlich Pharma brings together what has been an excellent match for years. Meta Bone Scrapers and our biomaterials Geistlich Bio-Oss® and Geistlich Bio-Gide® are typically used together in oral regeneration.

Both companies are family-owned and committed to the long-term perspective. Both partners are also distinguished by the fact that they are recognized as the gold standard in their respective business fields and enjoy a corresponding reputation. Over the last few years, a trust-based and appreciative cooperation has developed, with Geistlich distributing Meta's products in numerous markets.

All 15 employees have been taken on and will continue to be employed under the previous leadership of General Manager Corrado Saverio Parmigiani. This means that Meta Technologies S.r.l. will continue its business relationships independently and existing contacts at Meta remain unchanged.

A valued partner has become an integral part of Geistlich Pharma and provides the opportunity to expand our range in the field of medical regeneration. Geistlich extends a warm welcome to the Meta Technologies S.r.l. team.

In the picture (f.l.t.r.): Ralf P. Halbach, CEO Geistlich Pharma and Corrado Saverio Parmigiani, General Manager Meta Technologies S.r.l.